Abstract

Exome sequencing has revealed the causative mutations behind numerous rare, inherited disorders, but it is challenging to find reliable epidemiological values for rare disorders. Here, I provide a genetic epidemiology method to identify the causative mutations behind rare, inherited disorders using two population exome sequences (1000 Genomes and NHLBI). I created global maps of carrier rate distribution for 18 recessive disorders in 16 diverse ethnic populations. Out of a total of 161 mutations associated with 18 recessive disorders, I detected 24 mutations in either or both exome studies. The genetic mapping revealed strong international spatial heterogeneities in the carrier patterns of the inherited disorders. I next validated this methodology by statistically evaluating the carrier rate of one well-understood disorder, sickle cell anemia (SCA). The population exome-based epidemiology of SCA [African (allele frequency (AF) = 0.0454, N = 2447), Asian (AF = 0, N = 286), European (AF = 0.000214, N = 4677), and Hispanic (AF = 0.0111, N = 362)] was not significantly different from that obtained from a clinical prevalence survey. A pair-wise proportion test revealed no significant differences between the two exome projects in terms of AF (46/48 cases; P > 0.05). I conclude that population exome-based carrier rates can form the foundation for a prospectively maintained database of use to clinical geneticists. Similar modeling methods can be applied to many inherited disorders.

Highlights

  • Recent advances in next-generation sequencing (NGS) technology have revolutionized the field of clinical genetics [1,2,3,4]

  • This technology has facilitated the identification of the novel causative genes for >3,000 inherited disorders, which are currently annotated in the Online Mendelian Inheritance in Man (OMIM) [2, 3]

  • These populations under the study are likely depleted for individuals with rare genetic disorders, but when the prevalence rates are so close to 0 (

Read more

Summary

Introduction

Recent advances in next-generation sequencing (NGS) technology have revolutionized the field of clinical genetics [1,2,3,4]. This technology has facilitated the identification of the novel causative genes for >3,000 inherited disorders, which are currently annotated in the Online Mendelian Inheritance in Man (OMIM) [2, 3]. Molecular genetic testing is already being applied to screen for these inherited disorders [6]. An integrated map of genetic variation from 1,092 human genomes. Nature. 2013; 493: 216–220. doi: 10.1038/ nature11690 PMID: 23201682

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.